Community Corner: Opening the Pandora's box of prenatal genetic testing

Nature Medicine

Volumn 17, Issue 3, 2011, Pages 250-251

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

AMNIOCENTESIS; ANEUPLOIDY; BLOOD ANALYSIS; CHORION VILLUS SAMPLING; COST CONTROL; DIAGNOSTIC ACCURACY; DNA SEQUENCE; DOWN SYNDROME; FALSE POSITIVE RESULT; GENETIC ANALYSIS; GENETIC SCREENING; HEALTH CARE COST; HUMAN; MATERNAL BLOOD; NON INVASIVE MEASUREMENT; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SPONTANEOUS ABORTION; TRISOMY 13; TRISOMY 18; TRISOMY 21;

GENETIC TESTING; HUMANS; PRENATAL DIAGNOSIS;

EID: 79952392099     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0311-250     Document Type: Short Survey

References (11)

1. Chiu, R.W. et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Br. Med. J. published online, doi:10.1136/bmj.c7401 (11 January 2011).
2. Lo, Y.M.D. et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485-487 (1997).
3. Hall, A., Bostanci, A. & Wright, C.F. Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics 13, 246-255 (2010).
4. Fan, H.C. et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl. Acad. Sci. USA 105, 16266-16271 (2008).
5. Fan, H.C. & Quake, S.R. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS ONE 5, e10439 (2010).
6. Driscoll, D.A. et al. Screening for Down syndrome: changing practice of obstetricians. Am. J. Obstet. Gynecol. 200, 459.e1-459.e9 (2009).
7. Malone, F.D. et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N. Engl. J. Med. 353, 2001-2011 (2005). (Pubitemid 41609093)
8. Lo, Y.M., et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci. Transl. Med. 2, 61ra91 (2010).
9. Wald, N.J. et al. First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS). J. Med. Screen. 10, 56-104 (2003). (Pubitemid 36734906)
10. Borrell, A., Borobio, V., Bestwick, J.P. & Wald, N.J. Ductus venosus pulsality index as an antenatal screening marker for Down's syndrome: use with the combined and integrated tests. J. Med. Screen. 16, 112-118 (2009).
11. Bestwick, J.P., Huttly, W.J. & Wald, N.J. Distribution of nuchal translucency in antenatal screening for Down's syndrome. J. Med. Screen. 17, 8-12 (2010).